Pages
All Departments
Let's get Social
Copyright Here. All rights reserved.
BYWWW.NEJM.ORGJuly 14, 2017
An improvement in overall survival among patients with metastatic melanoma has been an elusive goal. In this phase 3 study, ipilimumab — which blocks cytotoxic T ...